Pembrolizumab in Untreated B-Cell Non-Hodgkin Lymphoproliferative Diseases
University of Washington
University of Washington
University of Washington
Columbia University
Dana-Farber Cancer Institute
Janssen Research & Development, LLC
MEI Pharma, Inc.
Amgen
Fondazione Italiana Linfomi - ETS
MEI Pharma, Inc.
Genmab
Academic and Community Cancer Research United
Xenikos
Altor BioScience
University of California, San Francisco
University of Chicago
Ipsen
Amgen
Memorial Sloan Kettering Cancer Center
Stanford University
ADC Therapeutics S.A.
SecuraBio
SecuraBio
University of Nebraska
University of Nebraska
Gilead Sciences
TG Therapeutics, Inc.
Eastern Cooperative Oncology Group
Asana BioSciences
Fred Hutchinson Cancer Center
Medical College of Wisconsin
Regeneron Pharmaceuticals
Spectrum Pharmaceuticals, Inc
Hoffmann-La Roche
Rush University Medical Center
Regeneron Pharmaceuticals
ADC Therapeutics S.A.
Spectrum Pharmaceuticals, Inc
Columbia University
Fred Hutchinson Cancer Center
Gilead Sciences
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Baylor College of Medicine
M.D. Anderson Cancer Center
Novartis
Hutchmed
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
City of Hope Medical Center